ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,677Medicare Part D Prescriptions Filled, Including Refills

Rank: 379 out of 944

$338K Total Retail Price of All Prescriptions

Rank: 428 out of 944

339 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 339 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 339 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 6,058 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 315 293 1 2
FUROSEMIDE 274 243 2 6
METOPROLOL TARTRATE 256 240 3 8
AMLODIPINE BESYLATE 247 239 4 5
SIMVASTATIN 200 181 5 1
OMEPRAZOLE 146 130 6 4
WARFARIN SODIUM 140 128 7 7
ALENDRONATE SODIUM 135 135 8 20
CRESTOR 128 113 9 28
LISINOPRIL 124 114 10 3
PANTOPRAZOLE SODIUM 123 111 11 34
METFORMIN HCL 104 87 12 12
HYDROCODONE-ACETAMINOPHEN 104 92 S3 12 10
PRAVASTATIN SODIUM 92 89 14 17
HYDROCHLOROTHIAZIDE 86 75 15 9
TRAMADOL HCL 84 82 16 21
POTASSIUM CHLORIDE 79 79 17 15
NEXIUM 78 27 18 53
METOPROLOL SUCCINATE 77 77 19 14
MELOXICAM 74 69 20 68
MIRTAZAPINE 73 60 21 35
QUETIAPINE FUMARATE 72 63 22 69
NAMENDA 70 58 23 37
CIPROFLOXACIN HCL 69 69 24 90
CLOPIDOGREL 68 65 25 36
GLYBURIDE 67 67 R 26 63
ISOSORBIDE MONONITRATE ER 66 66 27 52
ATENOLOL 66 66 27 11
CARVEDILOL 64 53 29 30
DIOVAN HCT 64 53 29 108
CITALOPRAM HBR 64 50 29 19
DIOVAN 64 64 29 38
SPIRONOLACTONE 63 50 33 44
ZOLPIDEM TARTRATE 63 59 33 25
SERTRALINE HCL 58 43 35 23
AZITHROMYCIN 55 50 36 70
ATORVASTATIN CALCIUM 52 51 37 13
PLAVIX 50 45 38 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 19, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.